In Nalpropion Pharmaceuticals v. Actavis
Laboratories FL, Inc., No. 2018-1221 (Fed. Cir. Aug. 15,
2019), the Court addressed whether a particular claimed dissolution
profile had the requisite written description support when the
specification described dissolution data obtained using the USP
Apparatus 1 Basket Method, whereas the specifically claimed
dissolution profile was obtained using the USP Apparatus Paddle 2
Method.
In this Hatch-Waxman litigation, the proposed generic
manufacturer argued that a particular asserted claim from one of
the Orange Book listed patents lacked written description support
because (i) the claim recited a specific dissolution profile that
was collected using the USP Apparatus 2 Paddle Method, but (ii) the
specification disclosed several tables of dissolution profile data
collected using the USP Apparatus 1 Basket Method. The district
court found credible the plaintiff's expert's statement
that the claimed dissolution profile and the